weight loss medicines

Actionable Insights Powered by AI

OrsoBio Secures $67 Million in Funding for Next-Generation Obesity Treatments

OrsoBio, obesity drugs, Eli Lilly, Series B funding, weight loss medicines, metabolic disorders